Avanir Pharmaceuticals, Inc.

Company Details

Name:	Avanir Pharmaceuticals, Inc.
Jurisdiction:	Rhode Island
Entity type:	Foreign Corporation
Status:	Activ
Date of Organization in Rhode Island:	17 Sep 2020 (5 years ago)
Identification Number:	001712954
Place of Formation:	DELAWARE
Principal Address:	30 ENTERPRISE SUITE 200, ALISO VIEJO, CA, 92656, USA
Purpose:	AVANIR IS A BIOPHARMACEUTICALS COMPANY FOCUSED ON ACQUIRING, DEVELOPING, AND COMMERCIALIZING NOVEL THERAPEUTIC PRODUCTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS.

Industry & Business Activity

NAICS

325412 Pharmaceutical Preparation Manufacturing

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Learn more at the U.S. Census Bureau

Agent

Name	Role	Address
CT CORPORATION SYSTEM	Agent	450 VETERANS MEMORIAL PARKWAY SUITE 7A, EAST PROVIDENCE, RI, 02914, USA

PRESIDENT

Name	Role	Address
LOUIS ALLESANDRINE	PRESIDENT	30 ENTERPRISE, SUITE 200 ALISO VIEJO, CA 92656 USA

TREASURER

Name	Role	Address
JOHN WILSON	TREASURER	30 ENTERPRISE, SUITE 200 ALISO VIEJO, CA 92656 USA

SECRETARY

Name	Role	Address
KERIANN MASTERS	SECRETARY	30 ENTERPRISE, SUITE 200 ALISO VIEJO, CA 92656 USA

CFO

Name	Role	Address
JAMES SAUER	CFO	30 ENTERPRISE, SUITE 200 ALISO VIEJO, CA 92656 USA

DIRECTOR

Name	Role	Address
DON HAYDEN	DIRECTOR	30 ENTERPRISE, SUITE 200 ALISO VIEJO, CA 92656 USA
TOM DESROSIER	DIRECTOR	30 ENTERPRISE, SUITE 200 ALISO VIEJO, CA 92656 USA

Filings

Number	Name	File Date
202451971650	Annual Report	2024-04-22
202333588420	Annual Report	2023-04-21
202214665000	Annual Report	2022-04-13
202192690290	Annual Report	2021-02-24
202055708030	Application for Certificate of Authority	2020-09-17

Date of last update: 28 Oct 2024

Sources: Rhode Island Department of State